2-Chlorodeoxyadenosine for multiple myeloma.
Niesvizky
R
R
Siegel
D
D
Michaeli
J
J
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D004249:DNA Damage; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D017338:Cladribine